Cannabis use is associated with a lower risk for alcohol-associated liver disease in patients with alcohol use disorder.

Tezepelumab reduced exacerbations across all seasons in severe uncontrolled asthma, even among patients with perennial and seasonal allergies.

For those with ALK+ NSCLC who received first-line, next-generation ALK TKI monotherapy, continuing ALK TKI with chemotherapy is linked to better outcomes.

Risk factors for rheumatoid arthritis-related lung diseases include later RA onset, longer RA duration, and previous pulmonary infections.

The GOLD COPD Update 2026 provides updated guidance on case-finding, disease activity, exacerbation management.

Diabetes care can greatly benefit from the implementation of telemedicine, but older adults still face accessibility barriers ...

Elexacaftor-tezacaftor-ivacaftor (ETI) may improve bronchial dilatations in adolescents with cystic fibrosis (CF).

In high-income areas, CV mortality generally declined in those with and without diabetes, but HF mortality reductions were smaller than atherosclerotic disease mortality.

Late-onset asthma risk is associated with numerous lifestyle-related metabolites, particularly among women, according to study findings published in The Journal of Allergy and Clinical Immunology.

Adding lactate trajectory classification into the SOFA score improved its accuracy in predicting mortality in sepsis-associated acute lung injury.

Many practicing allergist-immunologists report facing challenges in diagnosing and managing patients with inborn errors of immunity (IEIs).

For adults with VTE, continuing oral anticoagulants of at least 90 days is associated with a lower risk for recurrent VTE and a net clinical benefit.